|
Delaying or prevent Type 2 diabetes (Jewish World Review)
http://www.JewishWorldReview.com | Diabetes affects millions of Americans and is growing at epidemic rates. There is some good news, however. According to the American Diabetes Association, by making some lifestyle changes, many people can delay or prevent Type 2 diabetes.
us.rd.yahoo.com
OSI Pharmaceuticals Initiates Clinical Development Program For Anti-Diabetes Candidate, PSN821 (Medical News Today)
OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced that it has initiated a first-in-human clinical study for its G-protein coupled receptor GPR119 agonist, PSN821, which the Company is developing for the treatment of type 2 diabetes.
us.rd.yahoo.com
UPI NewsTrack Health and Science News (UPI)
Robotic helicopters teach themselves … New diabetes cell therapy is suggested … NASA creates Carl Sagan fellowships … New surgery stops Parkinson's cell loss ..... Health/Science news from UPI.
us.rd.yahoo.com
OSI Pharmaceuticals Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821 (Centre Daily Times)
OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that it has initiated a first-in-human clinical study for its G-protein coupled receptor GPR119 agonist, PSN821, which the Company is developing for the treatment of type 2 diabetes. Discovered by OSI's diabetes and obesity research team, PSN821 demonstrated both effective glucose lowering and substantial reductions of body weight in ...
us.rd.yahoo.com
Biodel To Report Results Of VIAject™ Pivotal Phase III Clinical Trials At EASD Conference (Medical News Today)
Biodel Inc. (Nasdaq: BIOD) announced that it will report results of its two pivotal Phase III clinical trials of VIAject™ in patients with Type 1 and Type 2 diabetes next week at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome. Two posters summarizing these results, #677 by Flacke et al.
us.rd.yahoo.com
Patients waiting 13 months to undergo diabetes tests (Malta Star)
Patients who are diagnosed to be suffering from diabetes are made to wait for 13 months before they undergo tests to confirm whether they are suffering from this chronic condition.
us.rd.yahoo.com
OSI Pharmaceuticals Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821 (Business Wire via Yahoo! Finance)
MELVILLE, N.Y.----OSI Pharmaceuticals, Inc. announced today that it has initiated a first-in-human clinical study for its G-protein coupled receptor GPR119 agonist, PSN821, which the Company is developing for the treatment of type 2 diabetes.
us.rd.yahoo.com
(AFX UK Focus) 2008-09-05 17:01 Novo Nordisk says FDA may delay Liraglutide ruling (Interactive Investor)
STOCKHOLM, Sept 5 (Reuters) - Danish pharmaceuticals group Novo Nordisk said on Friday an assessment by the U.S. Food and Drug Administration of its type 2 diabetes drug Liraglutide is likely to be delayed by some two months.
us.rd.yahoo.com
Physicians Eager To Increase Their First- And Second-Line Prescriptions For Januvia Over The Next Two Years For The ... (Medical News Today)
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Merck's Januvia is currently prescribed most often as a third- or later-line of therapy for the treatment of type 2 diabetes.
us.rd.yahoo.com
Battling Diabetes With Beta Cells (Medical News Today)
Affecting eight percent of America's population, diabetes can lead to blindness, kidney failure, strokes and heart disease. Thanks to Tel Aviv University researchers, a new cure - based on advances in cell therapy - may be within reach. Prof.
us.rd.yahoo.com
|
